Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ABSCFOTCMKTS:FFNTFOTCMKTS:TGIFFOTCMKTS:TSMRF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABSCFAB Science$1.26$1.52$0.80▼$1.60N/AN/A200 shsN/AFFNTF4Front Ventures$0.00-40.0%$0.00$0.00▼$0.11N/AN/A1.37 million shs570,300 shsTGIFF1933 Industries$0.00+10.5%$0.00$0.00▼$0.01N/AN/A137,556 shs3,768 shsTSMRFTsumura & Co.$28.15$28.15$28.15▼$28.15N/AN/A800 shsN/A20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABSCFAB Science0.00%0.00%-21.25%-19.75%-53.33%FFNTF4Front Ventures0.00%+25.00%-66.67%-97.02%-99.44%TGIFF1933 Industries0.00%-5.00%-37.70%-43.28%-51.28%TSMRFTsumura & Co.0.00%0.00%0.00%0.00%+5.19%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABSCFAB ScienceN/AN/AN/AN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/AN/AN/AN/AN/AN/AN/ATSMRFTsumura & Co.N/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABSCFAB Science 0.00N/AN/AN/AFFNTF4Front Ventures 0.00N/AN/AN/ATGIFF1933 Industries 0.00N/AN/AN/ATSMRFTsumura & Co. 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABSCFAB ScienceN/AN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/AN/AN/AN/AN/ATSMRFTsumura & Co.N/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABSCFAB ScienceN/AN/A0.00∞N/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/A0.00∞N/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/A0.00∞N/AN/AN/AN/AN/ATSMRFTsumura & Co.N/AN/A0.00∞N/AN/AN/AN/A8/4/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABSCFAB ScienceN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/AN/AN/AN/ATSMRFTsumura & Co.N/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABSCFAB ScienceN/AFFNTF4Front VenturesN/ATGIFF1933 IndustriesN/ATSMRFTsumura & Co.22.29%Insider OwnershipCompanyInsider OwnershipABSCFAB ScienceN/AFFNTF4Front VenturesN/ATGIFF1933 IndustriesN/ATSMRFTsumura & Co.N/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABSCFAB Science51N/AN/ANot OptionableFFNTF4Front Ventures460N/AN/ANot OptionableTGIFF1933 Industries87N/AN/ANot OptionableTSMRFTsumura & Co.4,032N/AN/ANot OptionableTSMRF, TGIFF, FFNTF, and ABSCF HeadlinesRecent News About These CompaniesTsumura Expands in China with Strategic AcquisitionJune 18 at 3:34 AM | tipranks.comTsumura & Co. Completes Share Repurchase ProgramJune 11, 2025 | tipranks.comTsumura & Co. Extends Employee Stock Delivery System to Boost EngagementMay 11, 2025 | tipranks.comTsumura & Co. Revises Stock Compensation System to Align with Long-term VisionMay 11, 2025 | tipranks.comTsumura & Co. Unveils Ambitious Growth Plan for 2025-2027May 11, 2025 | tipranks.comTsumura & Co. Reports Progress on Share Repurchase ProgramMay 11, 2025 | tipranks.comTsumura & Co. Reports Progress on Share Repurchase ProgramApril 7, 2025 | tipranks.comTsumura & Co. Finalizes Share Offering to Boost Market PositionMarch 4, 2025 | tipranks.comTsumura & Co. Finalizes Treasury Share Acquisition PlanMarch 4, 2025 | tipranks.comTsumura Revises Earnings Forecast Amid Sales ChallengesFebruary 6, 2025 | tipranks.comDuchess Park downs Notre Dame to win Tsumura Basketball InvitationalDecember 15, 2024 | myprincegeorgenow.comRiverside Rapids fall at Tsumura Invitational tournament, will play for third placeDecember 14, 2024 | tricitynews.comSDSS senior girls go 1-1 at Tsumura Basketball InvitationalDecember 13, 2024 | delta-optimist.comTsumura & Co. Strengthens Governance for Sustainable GrowthDecember 4, 2024 | tipranks.comTop B.C. basketball teams compete at Tsumura InvitationalDecember 4, 2024 | saanichnews.comHonda to launch three new models in India in 2026-27: CEO TsumuraDecember 4, 2024 | business-standard.comAbbotsford teams headed to Howard Tsumura Basketball InvitationalDecember 3, 2024 | abbynews.comARET Arête Industries, Inc.October 17, 2024 | seekingalpha.comTsumura & Co. (TSMRF)July 19, 2024 | ca.finance.yahoo.comMirann Tsumura-Hughes goes from accidental engineer to partner in companyMay 15, 2024 | bizjournals.comMedia Sentiment Over TimeTSMRF, TGIFF, FFNTF, and ABSCF Company DescriptionsAB Science OTCMKTS:ABSCF$1.26 0.00 (0.00%) As of 06/18/2025AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.4Front Ventures OTCMKTS:FFNTF$0.0003 0.00 (-40.00%) As of 03:56 PM Eastern4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates through THC Cannabis and CBD Wellness segments. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services. This segment sells equipment, supplies, and intellectual property to cannabis producers; and leases real estate properties. The CBD Wellness segment sells non-THC hemp derived products. In addition, it operates dispensaries in the Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.1933 Industries OTCMKTS:TGIFF$0.0042 +0.00 (+10.53%) As of 10:51 AM Eastern1933 Industries Inc., together with its subsidiaries, engages in the cultivation and production of cannabis products in the United States. It operates in three segments: the Medical Segment, the Recreational Segment, and the CBD-Infused Products Segment. The company produces, packages, and markets cannabidiol (CBD)-infused products, including tinctures, vape pens and cartridges, lotions, pain creams, gummies, and capsules under the Canna Hemp and Canna Hemp X brand names. It also offers craft-style cannabis, infused pre-rolls, full spectrum oils, distillates, terpenes, and vaporizer products; and boutique concentrates, such as shatters, crumbles, batters, sugar waxes, diamonds, and cured and live resins under the AMA and Level X brand names. The company offers its products through retail dispensaries and retail outlets, as well as through its e-commerce platform. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. is headquartered in Vancouver, Canada.Tsumura & Co. OTCMKTS:TSMRF$28.15 0.00 (0.00%) As of 06/18/2025Tsumura & Co. manufactures and sells pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
